GleamWall
中文EN

VANI Vivani Medical, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1266806 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-3.9%
TTM EPS YoY26.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-372.2%
ROA-89.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets62.6%
Debt / equity0.00x
Current ratio2.40x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.94x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0$0
R&D expense$18.13M$15.74M
SG&A expense$9.43M$8.93M
Operating income-$27.56M-$24.68M
Pretax income-$26.61M-$23.49M
Income tax—$2,000
Net income-$26.61M-$23.49M
EBITDA-$27.13M-$24.28M
EPS (basic)-0.43-0.43
EPS (diluted)-0.43-0.43
Weighted avg. shares (diluted)62.39M54.98M
Balance sheet
Cash & equivalents$16.23M$18.35M
Current assets$17.90M$20.44M
PP&E, net$2.88M$1.69M
Total assets$39.39M$41.56M
Current liabilities$6.60M$5.99M
Total liabilities$23.66M$23.95M
Shareholders' equity$15.73M$17.61M
Shares outstanding76.43M59.23M
Cash flow statement
Operating cash flow-$24.32M-$20.79M
Capital expenditure$1.17M$556,000
Free cash flow-$25.49M-$21.34M
Investing cash flow-$1.17M-$556,000
Financing cash flow$23.27M$19.05M
Depreciation & amortization$424,000$400,000
Stock-based compensation$1.48M$1.61M

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.